Table 2 Concomitant APS, affective stabilizers, and antidepressants between the two groups during the trial
Variables | Topiramate (n) | Metformin (n) | χ2/t | P value |
|---|---|---|---|---|
The number of combined use of APS, affective stabilizers and antidepressants | 18 | 27 | Â | |
Types of combined use of APS, and etc. | ||||
 Clozapine | 2 | 0 | 11.01 |  > 0.05 |
 Olanzapine | 0 | 3 |  |  |
 Quetiapine | 2 | 1 |  |  |
 Risperidone | 4 | 5 |  |  |
 Ziprasidone | 2 | 1 |  |  |
 Aripiprazole | 2 | 4 |  |  |
 Perphenazine | 4 | 9 |  |  |
 Chlorpromazine | 1 | 0 |  |  |
 Sulpiride | 0 | 1 |  |  |
 Lithium carbonate | 0 | 1 |  |  |
 Sodium valproate | 0 | 1 |  |  |
 Antidepressants | 1 | 1 |  |  |
CPZ equivalent daily dose of combined use of APS | 242.35 ± 198.26 | 342.50 ± 232.45 | 1.44 |  > 0.05 |